美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Definium Therapeutics

38.89

+1.163.07%

盤後：39.000.1100+0.28%19:55 EDT

成交量：175.43萬

成交額：6,813.15萬

市值：52.26億

市盈率：-11.17

高：39.37

開：37.73

低：37.73

收：37.73

52周最高：49.70

52周最低：8.77

股本：1.34億

流通股本：1.31億

量比：1.28

換手率：1.34%

股息：- -

股息率：- -

每股收益(TTM):-3.4823

每股收益(LYR):-2.0600

淨資產收益率：-64.09%

總資產收益率：-20.64%

市淨率：5.69

市盈率(LYR):-18.88

資料載入中...

總覽公司新聞公告

異動解讀｜Definium Therapeutics盤中上漲5.09%，DT120三期臨床成功疊加鉅額融資提振市場信心

異動解讀｜Definium Therapeutics盤中下跌5.02%，報44.68美元

異動解讀｜Definium Therapeutics盤中上漲5.04%，DT120三期臨床積極疊加8億美元增發落地提振信心

Definium Therapeutics 宣佈完成8.05億美元增發，承銷商全額行使超額配售權

異動解讀｜Definium Therapeutics盤中上漲9.07%，核心管線3期研究達成主要終點及7億美元增發定價落地

異動解讀｜Definium Therapeutics盤中上漲15.48%，核心管線3期研究達成主要終點疊加投行大幅上調目標價

Definium Therapeutics(DFTX)宣佈7億美元增發公開募股定價每股34美元

美國研究綜述-Apogee Therapeutics、通用電氣醫療集團、新思科技

市場聚焦：Definium Therapeutics股價因強勁致幻劑試驗結果飆升

BUZZ-Definium Therapeutics宣佈5億美元股權融資後股價下跌

BUZZ——美國股市動態-維斯通、英賽特、阿波吉

BUZZ-Definium Therapeutics股價大漲，因其抗抑鬱藥物晚期臨床試驗數據表現良好

Definium Therapeutics股價盤前飆升18.5%，其基於LSD的抑鬱藥物在後期試驗中顯效

Definium公司基於LSD的藥片在晚期臨床試驗中減輕了抑鬱症狀

Definium Therapeutics公布DT120口崩片治療重度抑鬱症的3期EMERGE研究積極頂線結果

Definium Therapeutics：DT120口崩片研究達成主要及所有關鍵次要療效終點

Definium Therapeutics 公布 DT120 ODT 臨床數據：總體耐受性良好，未出現嚴重不良事件或自殺傾向信號

Definium Therapeutics將於2026年6月22日討論重度抑鬱症III期EMERGE研究的頂線結果

Definium Therapeutics宣佈在DT120 Odt針對重度抑鬱症的第二個三期關鍵研究「Ascend」中完成首例患者給藥

異動解讀 | 特朗普簽署迷幻藥監管支持行政命令，Definium Therapeutics盤前大漲6.34%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/DFTX/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":38.89,"timestamp":1789156800000,"preClose":37.73,"halted":0,"volume":1754315,"hourTrading":{"tag":"盘后","latestPrice":39,"preClose":38.89,"latestTime":"19:55 EDT","volume":348208,"amount":13541995.6704,"timestamp":1789170913353,"change":0.11,"changeRate":0.002828,"amplitude":0.016804},"delay":0,"changeRate":0.03074476543864309,"floatShares":131114280,"shares":134366950,"eps":-3.482311,"marketStatus":"休市中","change":1.16,"latestTime":"09-11 16:00:00 EDT","open":37.73,"high":39.37,"low":37.73,"amount":68131498.355375,"amplitude":0.043467,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":37.73,"preHourTrading":{"tag":"盘前","latestPrice":37.9852,"preClose":37.73,"latestTime":"09:18 EDT","volume":4465,"amount":169832.67781,"timestamp":1789132705128,"change":0.2552,"changeRate":0.006764,"amplitude":0.020448},"postHourTrading":{"tag":"盘后","latestPrice":39,"preClose":38.89,"latestTime":"19:55 EDT","volume":348208,"amount":13541995.6704,"timestamp":1789170913353,"change":0.11,"changeRate":0.002828,"amplitude":0.016804},"volumeRatio":1.2818231822401762,"impliedVol":1.3321,"impliedVolPercentile":0.8963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":131114280,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":1.2818231822401762,"shares":134366950,"dividePrice":0,"high":39.37,"amplitude":0.043467,"preClose":37.73,"low":37.73,"week52Low":8.7732,"pbRate":"5.69","week52High":49.7,"institutionHeld":0,"latestPrice":38.89,"eps":-3.482311,"divideRate":0,"volume":1754315,"delay":0,"ttmEps":-3.482311,"open":37.73,"prevYearClose":13.39,"prevWeekClose":38.09,"prevMonthClose":39.72,"prevQuarterClose":47.04,"fiveDayClose":38,"twentyDayClose":43.9,"sixtyDayClose":24.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"盤後","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"盤後","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787025600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-09-11","current":-11.167871,"percent":0.337423,"low":-27.074722,"twenty":-17.27056,"median":-11.195675,"eighty":-9.903787,"high":-8.802064,"avg":-13.932943,"sd":5.402262,"marketCap":5069665023},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530},{"date":"2026-08-28","current":-16.642763,"twenty":-17.426666,"median":-11.092954,"eighty":-9.887379,"marketCap":5887959749},{"date":"2026-09-04","current":-14.432336,"twenty":-17.33018,"median":-11.139168,"eighty":-9.901443,"marketCap":5105944100},{"date":"2026-09-11","current":-14.329791,"twenty":-17.27056,"median":-11.195675,"eighty":-9.903787,"marketCap":5069665023}],"updateTime":1789285572520},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1143979950","title":"異動解讀｜Definium Therapeutics盤中上漲5.09%，DT120三期臨床成功疊加鉅額融資提振市場信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1143979950","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143979950?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 23:53","pubTimestamp":1783612422,"startTime":"0","endTime":"0","summary":"7月9日，Definium Therapeutics盘中上涨5.09%，报47.625美元/股，成交额6690.95万美元。消息面上，公司此前公布其核心产品DT120口崩片治疗重度抑郁症的3期EMERGE研究取得积极顶线结果，达到主要终点及所有关键次要疗效终点，安全性特征良好。RBC Capital随之将目标价由36美元大幅上调至57美元，维持\"跑赢大市\"评级。关键临床数据验证叠加充裕资金保障，持续推动股价上行。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137042231","title":"異動解讀｜Definium Therapeutics盤中下跌5.02%，報44.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137042231","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137042231?lang=zh_tw&edition=fundamental","pubTime":"2026-07-01 23:49","pubTimestamp":1782920992,"startTime":"0","endTime":"0","summary":"7月1日，Definium Therapeutics盘中下跌5.02%，报44.68美元/股，成交额4259.27万美元。Definium Therapeutics所在的制药行业中，个股中，礼来跌0.61%，强生跌0.66%，辉瑞跌0.69%，默沙东跌1.49%，诺和诺德涨2.69%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142122370","title":"異動解讀｜Definium Therapeutics盤中上漲5.04%，DT120三期臨床積極疊加8億美元增發落地提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1142122370","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142122370?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 22:03","pubTimestamp":1782828238,"startTime":"0","endTime":"0","summary":"6月30日，Definium Therapeutics盘中上涨5.04%，报48.84美元/股，成交额2163.95万美元。消息面上，公司近期利好密集释放。随后公司迅速启动增发融资，最终以每股34美元完成约2370万股的扩大规模公开发行，募资总额达8.05亿美元，承销商全额行使超额配售权，反映市场认购需求旺盛。此外，RBC Capital将公司目标价从36美元大幅上调至57美元，维持\"跑赢大盘\"评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160379075","title":"Definium Therapeutics 宣佈完成8.05億美元增發，承銷商全額行使超額配售權","url":"https://stock-news.laohu8.com/highlight/detail?id=1160379075","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160379075?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 04:25","pubTimestamp":1782419116,"startTime":"0","endTime":"0","summary":"Definium Therapeutics 公司已成功完成其增发规模达8.05亿美元的公开募股。此次发行规模较原计划有所扩大，并包含了承销商全额行使购买额外股份的选择权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111531466","title":"異動解讀｜Definium Therapeutics盤中上漲9.07%，核心管線3期研究達成主要終點及7億美元增發定價落地","url":"https://stock-news.laohu8.com/highlight/detail?id=1111531466","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111531466?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 22:26","pubTimestamp":1782397562,"startTime":"0","endTime":"0","summary":"6月25日，Definium Therapeutics盘中上涨9.07%，报45.595美元/股，成交额9796.98万美元。消息面上，公司于6月22日宣布其候选药物DT120口崩片在治疗重度抑郁症的关键3期EMERGE研究中达成主要终点及所有关键次要疗效终点，显示出统计学显著性和临床意义的改善。随后RBC Capital将目标价从36美元大幅上调至57美元，维持跑赢大盘评级。此外，公司于6月24日完成7亿美元扩大规模包销公开发行定价，每股34美元，募资将用于研发及一般企业用途。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186956929","title":"異動解讀｜Definium Therapeutics盤中上漲15.48%，核心管線3期研究達成主要終點疊加投行大幅上調目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1186956929","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186956929?lang=zh_tw&edition=fundamental","pubTime":"2026-06-24 22:00","pubTimestamp":1782309630,"startTime":"0","endTime":"0","summary":"6月24日，Definium Therapeutics盘中上涨15.48%，报42.42美元/股，成交额1.56亿美元。消息面上，公司于6月22日宣布其候选药物DT120口崩片在治疗重度抑郁症的关键3期EMERGE研究中取得积极顶线结果，达成主要终点及所有关键次要疗效终点，显示出与安慰剂相比具有统计学显著性和临床意义的改善，安全性特征与先前研究一致。随后RBC Capital将公司目标价从36美元大幅上调至57美元，维持跑赢大盘评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645889615","title":"Definium Therapeutics(DFTX)宣佈7億美元增發公開募股定價 每股34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645889615","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645889615?lang=zh_tw&edition=fundamental","pubTime":"2026-06-24 17:11","pubTimestamp":1782292315,"startTime":"0","endTime":"0","summary":"金吾财讯 | 临床后期生物制药公司Definium Therapeutics 正式宣布，其已完成扩大规模的包销公开发行定价，公司将以每股34.00美元的价格公开发行20,588,236股普通股。在不扣除承销折扣、佣金及其他发行费用的情况下，Definium预计此次公开发行的募资总额将达到约7亿美元。本次发行预计将于2026年6月25日左右交割。而就在本次发行定价前不久，Definium刚于6月22日宣布，其用于治疗重度抑郁症的创新疗法“DT120口崩片”在3期临床研究中取得了积极的顶线结果。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301833","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UUP","LENZ","UDN","BK4539","BK4007","DFTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645885082","title":"美國研究綜述-Apogee Therapeutics、通用電氣醫療集團、新思科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2645885082","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645885082?lang=zh_tw&edition=fundamental","pubTime":"2026-06-23 15:28","pubTimestamp":1782199726,"startTime":"0","endTime":"0","summary":"美国研究综述-Apogee Therapeutics、通用电气医疗集团、新思科技路透6月23日 - 周二，华尔街证券分析师调整了多家在美国上市公司的评级和目标股价，其中包括Apogee Therapeutics、通用电气医疗集团和新思科技。股票条目按字母顺序排列。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nL4S42V0H3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0719512351.SGD","ANEL","LU2463526074.USD","SNPX","SO","ABBV","LU1854104046.USD","APHU","LU2054465674.USD","LU0859254822.USD","ANET","LU1162221912.USD","IE00BMPRXQ63.HKD","ASH","DFTX","WEN","LU0203345920.USD","PIPR","SWKS","BK4196","LU0432979614.USD","WGS","HAWK","BK4550","CAR","LU0444971666.USD","LU1951200564.SGD","IE00BQXX3F31.USD","LU0289961442.SGD","LU1668664300.SGD","APGE","BK4186","LU0096362180.USD","MTB","LU0130102774.USD","LU0289739343.SGD","LU0957808578.USD","SNPS","LPX","WING","LU0511384066.AUD","APH","LU1003077747.HKD","TYL","FDXF","LU1496350502.SGD","BTI","LU1951198990.SGD","GEHC","DPZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115492046","title":"市場聚焦：Definium Therapeutics股價因強勁致幻劑試驗結果飆升","url":"https://stock-news.laohu8.com/highlight/detail?id=1115492046","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115492046?lang=zh_tw&edition=fundamental","pubTime":"2026-06-23 06:42","pubTimestamp":1782168168,"startTime":"0","endTime":"0","summary":"Definium Therapeutics的股价在周一暴涨50%，此前这家生物技术公司宣布，其LSD药物在一项后期临床试验中，单次剂量即可显著缓解抑郁症症状。\n这种名为DT120的药物，在医生用于追踪症状的60分量表上，单次给药六周后，比安慰剂的效果高出8.1分。这一疗效优势在三个月后依然得以保持。\nDT120是一种可在舌下溶解的、经药物配制的LSD版本。它属于一波正被研究人员用于测试治疗心理健康问题的致幻剂药物浪潮，这类药物还包括裸盖菇素和MDMA。\n分析师在一份研究报告中指出，这些试验结果“超出了预期，疗效清晰且非常稳健”。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645389070","title":"BUZZ-Definium Therapeutics宣佈5億美元股權融資後股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2645389070","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645389070?lang=zh_tw&edition=fundamental","pubTime":"2026-06-23 04:29","pubTimestamp":1782160182,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4S42U1LG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770993.USD","LU0187121727.USD","LU2357627491.SGD","LU1914381329.SGD","JPX","LU2552382058.USD","LU1032466523.USD","IE00B1XK9C88.USD","LU2242649171.HKD","IE00BKDWB100.SGD","LU0256863811.USD","LU2023250330.USD","IE00BWXC8680.SGD","LU1244550221.USD","LU1670627923.USD","IE00BLSP4452.SGD","IE0034235295.USD","LU1119994496.HKD","LU1366192091.USD","LU2211815571.USD","IE00BJTD4N35.SGD","LU2106854487.HKD","LU0208291251.USD","BK4566","LU1917777945.USD","IE000M9KFDE8.USD","LU0211327993.USD","LU0820562030.AUD","IE00BHPRN162.USD","IE00BZ1G4Q59.USD","LU2237443382.USD","LU2746668461.USD","LU0106831901.USD","LU1974910355.USD","LU0683600562.USD","LU1244550577.SGD","BK4550","IE00BDRTCR15.USD","LU0251132253.USD","LU2237443978.SGD","LU1894683348.USD","LU2244417387.USD","LU1629891620.HKD","LU0971096721.USD","JPMO","DFTX","LU1496350502.SGD","JPO","LU2023250504.SGD","LU2505996681.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645024879","title":"BUZZ——美國股市動態-維斯通、英賽特、阿波吉","url":"https://stock-news.laohu8.com/highlight/detail?id=2645024879","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645024879?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 19:54","pubTimestamp":1782129281,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4S42U0X9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRSH","LU0757428866.USD","IE00BK4W5M84.HKD","HOOX","LU1778281490.HKD","BK4581","HOOY","LU1145028129.USD","LU1548497426.USD","BK4551","LU0320765059.SGD","BK4574","LU0964807845.USD","BK4124","BK4527","LU2213496289.HKD","LU2023250330.USD","LU2063271972.USD","INCY","LU0210536198.USD","LU2108987350.USD","TSDD","LU0823411888.USD","TSLQ","TSYY","LU0466842654.USD","LU1674673691.USD","BK4548","IE00BWXC8680.SGD","LU2750360641.GBP","LU0198837287.USD","BK4007","LU2168564149.EUR","TSLO","HK0000914686.HKD","VC","TSLY","LU2420271590.USD","LU1232071149.USD","TSII","LU0053666078.USD","HOOZ","IE00B19Z8W00.USD","APGE","LU1839511570.USD","LU0345769128.USD","BK4592","SG9999015945.SGD","LU2290526834.HKD","RGNX","LU1720051017.SGD","ROBN","LU2168564495.EUR","BK4550","LU1914381329.SGD","LU2417539215.USD","LU2471134796.USD","LU0234572021.USD","TSLT","HOYY","LU1815336091.USD","SG9999015952.SGD","TSL","IE00BSNM7G36.USD","LU2168564065.EUR","BK4539","LU0820561909.HKD","LU2471134523.USD","07766","BK4555","LU2896262040.SGD","LU0097036916.USD","BK4543","LU1066051811.HKD","BK4598","IE00B19Z9505.USD","BK4213","LU0316494557.USD","LU2471134879.HKD","TSLR","HOOD","BK4127","LU0234570918.USD","LU1429558221.USD","LU1861558580.USD","GPRK","HOOG","LU0053671581.USD","TESL","LU0719512351.SGD","LU1267930730.SGD","LU2168563687.JPY","LU2471134952.CNY","HOII","LU2168564222.USD","LU2357305700.SGD","TSLI","LU2249611893.SGD","LU2750360997.AUD","HOOI","LU2250418816.HKD","LU0820561818.USD","LU0823414478.USD","BK4588","TSLW","09366","SG9999015978.USD","LU0056508442.USD","IE00B1XK9C88.USD","TLA","LU1366192091.USD","BK4533","LU0348723411.USD","BK4532","HODU","LU2360106780.USD","LU2756315664.SGD","LU0133085943.USD","LU2326559502.SGD","LU0109391861.USD","LU1861559042.SGD","IE00BK4W5L77.USD","LU1629891620.HKD","LU2087621335.USD","TSLL","07366","LU2360107168.USD","LU1551013342.USD","IE0034235303.USD","TSLA","BK4534","BK4585","LU0672654240.SGD","LU1551013425.SGD","BK4563","LU1435385759.SGD","LU1674673428.USD","LU2462157665.USD","LU2602419157.SGD","LU2403377893.USD","IE00B1BXHZ80.USD","LU1066051225.USD","LU1066053197.SGD","BK4099","DFTX","BK4505","BK4516","LU0082616367.USD","LU0077335932.USD","LU0345769631.USD","LU0708995401.HKD","LU1066051498.USD","LU0820562030.AUD","BK4604","TEST","LU0345770993.USD","TSLZ","LU1861215975.USD","IE00B19Z8X17.USD","TSLP","HOOW","LU2456880835.USD","LU0323591593.USD","LU1720051108.HKD","HK0000914660.USD","IE00BJLML261.HKD","TSLG","LU1861220033.SGD","09766","BK4612","LU0943347566.SGD","LU2236285917.USD","BK4511","TSLS","BK4139","IE00BZ199S13.USD","LU0345770308.USD","LU1852331112.SGD","LU2756315318.SGD","SG9999015986.USD","BK4547","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645033029","title":"BUZZ-Definium Therapeutics股價大漲，因其抗抑鬱藥物晚期臨床試驗數據表現良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2645033029","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645033029?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 19:13","pubTimestamp":1782126817,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4S42U0TI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169167287","title":"Definium Therapeutics股價盤前飆升18.5%，其基於LSD的抑鬱藥物在後期試驗中顯效","url":"https://stock-news.laohu8.com/highlight/detail?id=1169167287","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169167287?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 19:09","pubTimestamp":1782126566,"startTime":"0","endTime":"0","summary":"Definium Therapeutics的股价在盘前交易时段大幅上涨18.5%，这一显著波动源于公司公布了一项关键后期临床试验的积极结果。试验数据显示，该公司研发的一款基于LSD的口服药物，在减轻重度抑郁症症状方面展现出了显著疗效。这项突破性的研究成果为抑郁症治疗领域带来了新的希望，同时也极大地提振了市场对Definium Therapeutics未来前景的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029980","title":"Definium公司基於LSD的藥片在晚期臨床試驗中減輕了抑鬱症狀","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029980","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029980?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126036,"startTime":"0","endTime":"0","summary":"路透6月22日 - Definium Therapeutics公司周一表示，在一项晚期临床试验中，其基于LSD的试验性药片单次给药显著减轻了患者的重度抑郁症状。Definium公司的药物总体耐受性良好，99%的不良事件为轻度至中度，主要发生在给药当天，且未观察到严重的安全问题或自杀念头增加的情况。该公司表示，这些结果使其更接近向美国食品药品监督管理局提交申请，目前正在开展第二项抑郁症晚期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4S42U0R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109486940","title":"Definium Therapeutics公布DT120口崩片治療重度抑鬱症的3期EMERGE研究積極頂線結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1109486940","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109486940?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126018,"startTime":"0","endTime":"0","summary":"Definium Therapeutics宣布，其针对重度抑郁症（MDD）的候选药物DT120口崩片（ODT）在关键的3期EMERGE研究中取得了积极的顶线结果。该研究达到了其主要终点，显示出与安慰剂相比，在改善抑郁症状方面具有统计学显著性和临床意义的优势。安全性特征与先前研究一致，未发现新的安全问题。这一积极数据为DT120的后续监管申请奠定了坚实基础，标志着公司在精神疾病治疗领域的重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147229029","title":"Definium Therapeutics：DT120口崩片研究達成主要及所有關鍵次要療效終點","url":"https://stock-news.laohu8.com/highlight/detail?id=1147229029","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147229029?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126016,"startTime":"0","endTime":"0","summary":"Definium Therapeutics宣布，其候选药物DT120口崩片的一项临床研究，已成功达成预设的主要疗效终点以及所有关键性的次要疗效终点。这一积极结果标志着该药物在目标适应症的开发中取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138440350","title":"Definium Therapeutics 公布 DT120 ODT 臨床數據：總體耐受性良好，未出現嚴重不良事件或自殺傾向信號","url":"https://stock-news.laohu8.com/highlight/detail?id=1138440350","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138440350?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126014,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) 近日公布了其候选药物 DT120 口腔崩解片（ODT）的临床研究结果。数据显示，该药物在试验中总体耐受性良好，未观察到任何严重不良事件，也未发现与自杀倾向相关的信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194348262","title":"Definium Therapeutics將於2026年6月22日討論重度抑鬱症III期EMERGE研究的頂線結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1194348262","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194348262?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 05:01","pubTimestamp":1782075697,"startTime":"0","endTime":"0","summary":"Definium Therapeutics宣布，将于2026年6月22日就其针对重度抑郁症的III期EMERGE研究的顶线结果进行讨论。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137501338","title":"Definium Therapeutics宣佈在DT120 Odt針對重度抑鬱症的第二個三期關鍵研究「Ascend」中完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=1137501338","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137501338?lang=zh_tw&edition=fundamental","pubTime":"2026-05-12 19:01","pubTimestamp":1778583709,"startTime":"0","endTime":"0","summary":"Definium Therapeutics宣布，在其针对重度抑郁症的候选药物DT120 Odt的第二个关键性三期临床试验“Ascend”中，已完成对首例患者的给药。这标志着该药物临床开发项目的一个重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142902855","title":"異動解讀 | 特朗普簽署迷幻藥監管支持行政命令，Definium Therapeutics盤前大漲6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142902855","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142902855?lang=zh_tw&edition=fundamental","pubTime":"2026-04-21 17:11","pubTimestamp":1776762674,"startTime":"0","endTime":"0","summary":"Definium Therapeutics（股票代码：DFTX）今日盘前股价大幅上涨6.34%，引起了市场的广泛关注。消息面上，此次股价异动主要源于行业性的政策利好。据报道，美国总统特朗普签署了一项行政命令，要求卫生监管机构加快对伊博格碱等迷幻药的审查流程，并拨出5000万美元专款用于相关研究。此举被市场解读为政府对迷幻药治疗领域的正式认可与实质性支持，从而提振了投资者信心。受此消息影响，整个迷幻药开发板块应声上涨。分析人士指出，该行政命令标志着官方支持从“空谈”转向“真实可操作”，获得“突破性疗法”称号的迷幻药未来有望获得优先审查，从而大幅缩短审批时间，为相关公司带来发展机遇。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":48,"code":"91000000","status":"200"}]}}